Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome.
<h4>Objective</h4>Many patients with rheumatoid arthritis (RA) benefit from tumor necrosis factor-α blocking treatment (anti-TNF), but about one third do not respond. The objective of this study was to replicate and extend previously found associations between anti-TNF treatment response...
Guardado en:
Autores principales: | Jacob Sode, Ulla Vogel, Steffen Bank, Paal Skytt Andersen, Marianne Kragh Thomsen, Merete Lund Hetland, Henning Locht, Niels H H Heegaard, Vibeke Andersen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99897076b05c4c918622565bb3bb7063 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
The role of the NLRP3 inflammasome in gout
por: Sarah R Kingsbury, et al.
Publicado: (2011) -
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury SM, et al.
Publicado: (2021) -
The Role of NLRP3 Inflammasome in Lupus Nephritis
por: Camila Barbosa Oliveira, et al.
Publicado: (2021) -
Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer
por: Dev Karan, et al.
Publicado: (2017)